Airway Bacterial Colonization with Lung Cancer Requiring Chemotherapy
Received: 02-Nov-2022 / Manuscript No. jcidp-22-80927 / Editor assigned: 04-Nov-2022 / PreQC No. jcidp-22-80927 / Reviewed: 18-Nov-2022 / QC No. jcidp-22-80927 / Revised: 24-Nov-2022 / Manuscript No. jcidp-22-80927 / Published Date: 30-Dec-2022 DOI: 10.4172/2476-213X.1000163
Abstract
Bronchial colonization is frequently reported in patients with lung cancer, and has a potential impact on therapeutic management and prognosis. We aimed to prospectively define the prevalence and nature of bronchial colonisation in patients at the time of diagnosing lung cancer.210 consecutive patients with lung cancer underwent a flexible bronchoscopy for lung cancer. The type and frequency of bacterial, mycobacterial and fungal colonisation were analysed and correlated with the patients' and tumours' characteristics.
Potential pathogens were found in 48.1% of samples: mainly the Gram-negative bacilli Escherichia coli (8.1%), Haemophilus influenzae (4.3%) and Enterobacter spp. (2.4%); Gram-positive cocci, Staphylococcus spp. (12.9%) and Streptococcus pneumoniae (3.3%); atypical mycobacteria (2.9%); Candida albicans (42.9%); and Aspergillus fumigatus (6.2%). Aged patients (p=0.02) with chronic obstructive pulmonary disease (p=0.008) were significantly more frequently colonised; however, tumour stage, atelectasis, bronchial stenosis and abnormalities of chest radiography were not associated with a higher rate of colonisation. Squamous cell carcinoma tended to be more frequently colonised than other histological subtypes. Airway colonisation was reported in almost half of patients presenting with lung cancer, mainly in fragile patients, and was significantly associated with worse survival (p=0.005). Analysing colonisation status of patients at the time of diagnosis may help improve the management of lung cancer.
Keywords
Lung cancer; Bacterial colonization; Respiratory tract; Antibiotic-resistance
Introduction
Infections are a natural part of the course of lung cancer. Only a few studies have presented clinical and microbiological documentation of them in patients with the malignancy. However, some conditions exist in this group that makes it prone to infections. They are: immunodepression, neutropeny along with changes in endogenic bacterial flora and local inflammatory reaction caused by co-existing bronchiectases, and chronic obturatory pulmonary disease (COPD). Multi-directional treatment of patients with lung cancer can lead to the development of opportunistic infections [1]. The clinical course of lung cancer is often complicated by lung infections proved in 9.5% to 84% of cases. Their diagnosis is very difficult due to non-typical clinical presentation. The interpretation of x-ray images showing lobar inflammatory infiltration, atelectasis or pleural fluid is ambiguous.
It is estimated that the incidence of lung infections in patients who underwent pulmonary resection ranges from 2% to 20%. Previous colonization of the respiratory tract by potentially pathogenic microorganisms may increase the risk of post-operative infection and be a reason for lung infections in the natural course of lung cancer. Identification of bacteria colonizing the lower respiratory tract in patients with lung cancer may influence the choice of perioperative antibiotic prophylaxis and administration of a more efficient empiric antibiotic therapy for lung infections.
The objective of this study is to analyze the profile of potentially pathogenic bacterial strains colonizing the respiratory tract in patients with lung cancer [2].
Material and Methods
The analyzed group consisted of 44 patients with a primary malignant lung tumour aged from 38 to 77:34 males aged 38–77, and 10 females aged 46–77. In 36 (82.8%) cases non-small cell lung cancer (NSCLC) was diagnosed, anaplastic small cell carcinoma in six cases (13.6%) and carcinoid in two cases (4.5%). Twenty three tumours (52.3%) were in the right lung and 21 (47.7%) in the left one [3]. In six patients (13.6%) with small cell lung carcinoma (SCLC), localized disease was diagnosed in four cases (9.1%) and extended disease in two cases (4.5%).
In patients with NSCLC and carcinoid, stage IA was found in 13 cases (26.5%), stage IB in 22 cases (44.9%), stage IIB in four cases (8.2%), stage IIIA in five cases (10.2%), stage IIIB in one case (2.1%) and stage IV in two cases (4.1%). Fourteen patients (28.6%) were classified as T1 tumour, 32 patients as T2 (65.3%), two patients as T3 (4.1%) and one as T4 (2.1%). Thirteen patients (29.6%) out of the analyzed group underwent radical anatomical lung resection.
Two patients in the analyzed group were treated with inhalation drugs due to COPD. No other comorbidities in the patients could influence the development of pathological bacteria within the bronchial tree. Broncho fibroscopy was performed in each patient with a bronchofibroscope sterilized in ethylene oxide [4]. The bronchoscope was fixed during the procedure in the lobar bronchus where a tumour was localized and 150 ml of normal saline in fractionated doses was administered and then bronchoalveolar lavage (BAL) was removed from the bronchus by suction and collected in a sterile suction device. 10 ml out of the collected BAL (120 –130 ml) was separated for cytology. The rest was for microbiological examination. When BAL was collected, bronchial biopsy was performed if any pathology was found. 100 ml of the fluid was mixed in a vortex for approximately one minute and then a quantitative culture on growth media was made with calibrated loops and a culture for Gram (–) bacilli. The following media were used: Columbia Agar +5%, ram blood, chocolate Agar for Haemophilus and MacConkey’s Agar. The obtained material was also centrifuged and a microscopic specimen stained with Gram method was made of sediment. Cultures were incubated in conformity with regulations established for microbiological departments. The identification of bacteria and their antibiotic resistance was done by manual or automatic methods. Results were presented in cfu/ml [5]. To interpret quantitative cultures, a diagnostic level was set at ≥ 104 cfu/ml. The analysis comprised only potentially pathogenic microorganisms responsible for infections of the lower respiratory tract and present at the level of ≥ 104 cfu/ml.
Results
In 26 (59.1%) of 44 analyzed patients physiological bacterial flora was found in BAL. In three cases (6.8%), potentially pathogenic bacterial strains at the level of < 104 cfu/ml were detected, and in 15 cases (34.1%), at least one potentially pathogenic bacterial strain was present at the level of ≥ 104 cfu/ml [6]. Among bacteria isolated at the significant level were Gram-positive ones such as Streptococcus pneumoniae, Streptococcus agalactiae and Staphylococcus aureus and Gram-negative ones such as Haemophilus influenzae, Moraxella catarrhalis, Klebsiella oxytoca, Escherichia coli, Pseudomonas aeruginosa and Alcaligenes spp. The frequency of identified bacteria is presented in (Table 1). Polymicrobial flora was found in five patients. In four cases (9.1%) two, and in one case (2.3%) three, bacterial species were isolated at the level of ≥ 104 cfu/ml. Micro-organisms isolated from patients with positive cultures are presented in (Table 2). Three out of seven strains of S. pneumoniae were resistant to erythromycin and clindamycin and resistant or intermediately susceptible to tetracycline [7].
Characteristic | Patients n (%) |
---|---|
Histological types | |
Adenocarcinoma | 107 (51.2) |
Squamous cell carcinoma | 62 (29.7) |
Small cell carcinoma | 21 (10.0) |
Large cell carcinoma | 7 (3.3) |
Other | 12 (5.7) |
Staging | |
0 | 0 (0.0) |
I or II | 38 (11.9) |
III | 49 (24.4) |
IV | 114 (56.7) |
ND | 9 (4.7) |
T descriptor | |
T0 | 0 (0.0) |
T1 | 25 (11.9) |
T2 | 59 (28.1) |
T3 | 33 (17.6) |
T4 | 69 (32.9) |
TX | 5 (2.4) |
ND | 15 (7.1) |
N descriptor | |
N0 | 48 (22.9) |
N1 | 15 (7.1) |
N2 | 61 (29.0) |
N3 | 59 (28.1) |
NX | 12 (5.7) |
ND | 15 (7.1) |
M descriptor | |
M0 | 85 (40.5) |
M1 | 112 (53.3) |
ND | 13 (6.2) |
Microorganism |
n (%) ≥102cfu·mL−1 | % ≥102–<105cfu·mL−1 | % ≥105cfu·mL−1 |
---|---|---|---|
PPM | |||
Staphylococcus aureus | 27 (12.9) | 3.3 | 9.5 |
Escherichia coli | 17 (8.1) | 6.2 | 1.9 |
Proteus mirabilis | 14 (6.7) | 4.3 | 2.4 |
Haemophilus influenzae | 9 (4.3) | 2.4 | 1.9 |
Klebsiella oxytoca | 8 (3.8) | 1.4 | 2.4 |
Streptococcus pneumoniae | 7 (3.3) | 0.5 | 2.8 |
Serratia spp. | 6 (2.9) | 2.9 | 0 |
Enterobacter spp. | 5 (2.4) | 1 | 1.4 |
Pseudomonas aeruginosa | 5 (2.4) | 1.4 | 1 |
Morganella morganii | 1 (0.5) | 0 | 0.5 |
Stenotrophomonas maltophilia | 1 (0.5) | 0 | 0.5 |
Non-PPM | |||
Streptococcus viridans | 188 (89.5) | ||
Neisseria spp. | 95 (45.2) | ||
Haemophilus parainfluenzae | 91 (43.3) | ||
Rothia spp. | 18 (8.6) | ||
Corynebacterium spp. | 13 (6.2) | ||
Coagulase-negativeStaphylococcus | 10 (4.8) | ||
AtypicalMycobacterium | 6 (2.9) | ||
Aspergillus fumigatus | 13 (6.2) | ||
Candida albicans | 90 (42.9) | ||
No microorganism | 8 (3.8) |
One of the strains exhibited lowered susceptibility to penicillin but was susceptible to IIIgeneration cephalosporines. Two strains exhibited resistance and intermediate susceptibility to trimethoprim/ sulfamethoxazole respectively. All isolated strains of S. aureus were metycillin-susceptible. They were also susceptible to erythromycin, clindamycin and trimethoprim/sulfamethoxazole [8]. None of isolated strains of H. influenzae produced b-lactamase. However, one strain exhibited resistance to trimethoprim/sulfamethoxazole. M. catarrhalis produced no b-lactamase. Isolated strains of K. oxytoca and E. coli exhibited no ability to produce extended-spectrum b-lactamases (ESBLs). Similarly, among P. aeruginosa no multi-drug-resistant or metallo-b-lactamases (MBL) producing strains were found. Thirteen patients out of the 44 underwent radical anatomical lung resection. In this group, perioperative antibiotic prophylaxis was administered: four 2g doses intravenously every six hours. The first dose was administered 30 minutes before the induction of general anaesthesia. Before surgery, potentially pathogenic bacteria were isolated from BAL at the level of ≥ 104 cfu/ml in six patients and at the level of < 104 cfu/ml in two patients and physiological bronchial bacterial flora was detected in five cases. No post-operative infections of surgical wounds or the respiratory tract developed in the patients [9]. No infections of the lower respiratory tract were diagnosed in patients not undergoing surgery. In two patients with COPD, no positive cultures were present.
Discussion
Infections in patients with lung cancer, especially pulmonary ones, can thwart the effect of oncological treatment and affect the survival of patients. Mortality due to post-operative pneumonia in this group of patients is high and ranges from 22% to 67%. Berghmans et al., analyzing the localisation and frequency of infections in 275 patients with lung cancer, found that the most frequent were infections of the bronchial tree (56%) caused by S. pneumoniae, S. aureus, H. influenzae, E. coli, P. aeruginosa and M. catarrhalis. Other authors pay attention both to Gram-negative bacilli such as H. influenzae, K. pneumoniae, E. cloacae and P. aeruginosa isolated in 68% of patients and the Gram-positive coccus S. aureus [10]. The development of the lower respiratory tract infection is preceded by bacterial colonization. A relation was found between bacterial colonization of the bronchial tree and pneumonia in patients in intensive care units. A similar relation was found in cases of inflammatory complications in patients after pulmonary resections due to lung cancer.
Schussler et al. proved that post-operative pneumonia not only is diagnosed more frequently in patients with preceding bacterial colonization but also has earlier clinical manifestation during the post-operative period. Other authors found a statistically significant relation between the presence of H. influenzae in a pre-operative culture of sputum, pharyngeal swab and its tracheal colonization during intubation and pulmonary infections [11]. According to Sok et al., strains of pathogenic bacteria detected in BAL obtained from a resected lung in intraoperative aspirates from the bronchial tree, were a significant cause of inflammatory complications within the chest. Ioanas et al. estimated that bacterial colonization of the bronchial tree in patients with resectable lung cancer is as high as 41%. They were of the opinion that the risk factor of such colonization is central localization of a tumour and high body mass index (BMI). The authors, however, demonstrated no correlation between the colonization and post-operative pulmonary infections. In our study, potentially pathogenic micro-organisms responsible for the lower respiratory tract infections were found in 30% of patients. The most frequently isolated bacteria were Gram-positive cocci such as S. pneumoniae and S. aureus. However, S. pneumoniae was a dominant pathogen. The bacterium is the most frequent factor responsible for pulmonary infections including lobar pneumonia [12].
In patients who underwent surgery and were earlier colonized, S. pneumoniae causes early postoperative pneumonia. In the analyzed group of patients, we found no strains resistant to penicillin, but three out of seven examined isolates exhibited resistance to macrolide, lincosamide and streptogramin B (MLSB phenotype) that excludes the antibiotics from therapy. The analysis of antibiotic resistance shows no multi-drug-resistant strains. The isolated micro-organisms were susceptible to antibiotics commonly used for the treatment of respiratory tract infections. Our results are similar to those reported by Ionas et al. who also found no multi-drug-resistant bacterial strains in their clinical material. On the other hand, Radu et al. highlighted the need for verification of recommendations on perioperative antibiotic prophylaxis in thoracic surgery due to its low effectiveness. First generation cephalosporine used as a prophylaxis was inefficient in 84% of microbiologically documented post-operative pneumonias [13]. In our study, no pneumonias were observed, despite the fact that in some cases bacterial growth exceeded the level assumed as clinically significant. It should be emphasized, however, that only a small group of our patients with positive cultures underwent surgery. Due to the fact that postoperative infections in patients with lung cancer are a serious clinical problem, they require close co-operation between doctor and microbiologist. It seems appropriate to supervise bacterial colonization and infections in this group of patients. Supervision over bacterial flora colonizing the respiratory tract and its antibiotic resistance in relation to the stage of lung cancer and risk factors for infections, along with the analysis of post-operative infections in the patients, enables efficient perioperative antibiotic prophylaxis and should be the object of analysis on a bigger group of patients.
Conclusions
Approximately 30% of patients with lung cancer had a respiratory tract colonized by microorganisms whose number was higher than the assumed diagnostic level. Among micro-organisms colonizing the lower respiratory tract, Gram-positive cocci such as Streptococcus pneumoniae and Staphylococcus aureus were dominant. The analysis of antibiotic-resistance did not detect multi-drug-resistant microorganisms but some strains of Streptococcus pneumoniae exhibited resistance to macrolide, lincosamide and streptogramin B.
References
- Klastersky J, Aoun M (2004) Opportunistic infections in patients with cancer. Ann Oncol 15: 329–335.
- Klastersky J (1998) Les complications infectiousness du cancer bronchique. Rev Mal Respir 15: 451–459.
- Duque JL, Ramos G, Castrodeza J (1997) Early complications in surgical treatment of lung cancer: a prospective multicenter study. Ann Thorac Surg 63: 944–950.
- Kearny DJ, Lee TH, Reilly JJ (1994) Assessment of operative risk in patients undergoing lung resection. Chest 105: 753–758.
- Busch E, Verazin G, Antkowiak JG (1994) Pulmonary complications in patients undergoing thoracotomy for lung carcinoma. Chest 105: 760–766.
- Deslauriers J, Ginsberg RJ, Piantadosi S (1994) Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest 106: 329–334.
- Belda J, Cavalcanti M, Ferrer M (2000) Bronchial colonization and postoperative respiratory infections in patients undergoing lung cancer surgery. Chest 128:1571–1579.
- Perlin E, Bang KM, Shah A (1990) The impact of pulmonary infections on the survival of lung cancer patients. Cancer. 66: 593–596.
- Ginsberg RJ, Hill LD, Eagan RT (1983) Modern 30-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 86: 654–658.
- Schussler O, Alifano M, Dermine H (2006) Postoperative pneumonia after major lung resection. Am J Respir Crit Care Med 173: 1161–1169.
- Berghmans T, Sculier JP, Klastersky J (2003) A prospective study of infections in lung cancer patients admitted to the hospital. Chest 124: 114–120.
- Putinati S, Trevisani L, Gualandi M (1994) Pulmonary infections in lung cancer patients at diagnosis. Lung Cancer 11: 243–249.
- Bonten MJ, Weinstein RA (1996) The role of colonization in the pathogenesis of nosocomial infections. Infect Control Hosp Epidemiol 17: 193–200.
Indexed at, Google Scholar , Crossref
Indexed at, Google Scholar , Crossref
Indexed at, Google Scholar , Crossref
Indexed at, Google Scholar , Crossref
Indexed at, Google Scholar , Crossref
Indexed at, Google Scholar , Crossref
Indexed at, Google Scholar , Crossref
Indexed at, Google Scholar , Crossref
Indexed at, Google Scholar , Crossref
Indexed at, Google Scholar , Crossref
Indexed at, Google Scholar , Crossref
Citation: Takahiro K (2022) Airway Bacterial Colonization with Lung Cancer Requiring Chemotherapy. J Clin Infect Dis Pract, 7: 163. DOI: 10.4172/2476-213X.1000163
Copyright: © 2022 Takahiro K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 805
- [From(publication date): 0-2022 - Dec 19, 2024]
- Breakdown by view type
- HTML page views: 627
- PDF downloads: 178